Alkyl Amines Chemicals Limited has fixed Friday, June 26, 2026, as the record date to determine the eligibility of shareholders entitled to a dividend for the financial year ended March 31, 2026. The declaration of the dividend is contingent upon approval by shareholders at the upcoming Annual General Meeting (AGM). This announcement ensures that shareholders holding shares on the record date will be eligible to receive the payout if the proposal is cleared.

The 46th AGM of Alkyl Amines Chemicals is scheduled to be held on Friday, July 3, 2026, at 3:00 P.M. IST. The meeting will be conducted via video conferencing and other audio-visual means, in compliance with the provisions of the Companies Act, 2013, and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The record date was fixed in accordance with Regulation 42 of the SEBI Listing Regulations. The company stated that the purpose of fixing this date is strictly to identify members eligible for the dividend, pending its approval at the AGM.

Key Corporate Event Details

Alkyl Amines Chemicals Limited's Board of Directors approved the audited financial results for the quarter and financial year ended March 31, 2026. The board recommended a final dividend of ₹10 per equity share of ₹2 each (500%) for FY26, subject to shareholder approval. The company reported revenue from operations of ₹386.91 crores for Q4 FY26, compared to ₹386.05 crores in Q4 FY25. For the full year FY26, revenue stood at ₹1,535.85 crores against ₹1,571.82 crores in FY25. Net profit for the year was ₹180.00 crores, slightly lower than ₹186.11 crores in the previous year.

Q4 FY26 and Full-Year Financial Performance

On an operating profitability basis, Q4 EBITDA improved to 707M rupees from 682M rupees in Q4 FY25, with the EBITDA margin expanding to 18.30% from 17.67% year-on-year. The following table summarises the key financial metrics:

Management Commentary and Outlook

During the earnings conference call, management expressed cautious optimism for the coming year, expecting volume growth between 5% and 10% and better margins compared to the previous year. They noted that Chinese competition has become less aggressive, which may help restore margins. Regarding capacity, the company stated that plants are running at 60% to 85% utilization, and there is sufficient capacity for ethylamines for the next 4 to 5 years. However, the methylamines segment faces overcapacity due to a new entrant. The company also mentioned that a new product project at Dahej is slightly delayed and is expected to be commissioned by July.

Operational Updates and Guidance

Management addressed the challenges faced during the year, noting that both top-line and bottom-line growth remained flat. The company faced sourcing issues with ammonia in March due to geopolitical tensions, which led to a rise in raw material prices from around INR50 a kg to over INR100 a kg. However, the company managed to pass on these cost increases to customers, protecting margins. For FY27, the planned capex is expected to be around INR80 crores to INR90 crores, primarily for the Dahej project and engineering works.